JP2009534292A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534292A5
JP2009534292A5 JP2008544698A JP2008544698A JP2009534292A5 JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5 JP 2008544698 A JP2008544698 A JP 2008544698A JP 2008544698 A JP2008544698 A JP 2008544698A JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5
Authority
JP
Japan
Prior art keywords
moisture
measured
results
conditions
stored
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008544698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/059428 external-priority patent/WO2007126135A1/en
Publication of JP2009534292A publication Critical patent/JP2009534292A/ja
Publication of JP2009534292A5 publication Critical patent/JP2009534292A5/ja
Abandoned legal-status Critical Current

Links

JP2008544698A 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンｉｉ拮抗薬の医薬組成物 Abandoned JP2009534292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79517906P 2006-04-27 2006-04-27
PCT/JP2007/059428 WO2007126135A1 (en) 2006-04-27 2007-04-26 Pharmaceutical composition of angiotensin ii antagonists with pioglitazone hcl

Publications (2)

Publication Number Publication Date
JP2009534292A JP2009534292A (ja) 2009-09-24
JP2009534292A5 true JP2009534292A5 (enExample) 2010-04-30

Family

ID=38328300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544698A Abandoned JP2009534292A (ja) 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンｉｉ拮抗薬の医薬組成物

Country Status (6)

Country Link
JP (1) JP2009534292A (enExample)
AR (1) AR060663A1 (enExample)
CL (1) CL2007001195A1 (enExample)
PE (1) PE20080696A1 (enExample)
TW (1) TW200800299A (enExample)
WO (1) WO2007126135A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
CN101896171B (zh) * 2007-05-08 2012-05-23 陶氏环球技术公司 水分散性聚合物组合物
MX2014004679A (es) 2011-10-21 2014-08-01 Takeda Pharmaceutical Preparacion de liberacion sostenida.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW284688B (enExample) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US20040219208A1 (en) * 2001-08-03 2004-11-04 Ryu Kawamura Sustained-release medicines
MX2007003716A (es) * 2004-10-07 2007-04-23 Takeda Pharmaceutical Agente para la profilaxis o tratamiento del sindrome metabolico.

Similar Documents

Publication Publication Date Title
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
MX2010005087A (es) Formulacion solida de liberacion rapida, preparacion y uso de la misma.
JP2012031131A5 (enExample)
JP2010242999A5 (enExample)
IL212435A (en) Isoindulin compounds, their pharmaceutical compositions and their use in the preparation of drugs
JP2012158592A5 (enExample)
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
WO2011104652A3 (en) Veterinary compositions
CO6440564A2 (es) Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
JP2009534292A5 (enExample)
BR112014030160A2 (pt) composição formadora de película, uso de uma composição formadora de película, película e cápsula dura
HU0900376D0 (en) Nanoparticulate candesartan cilexetil composition, process for the preparation thereof and pharmaceutical compositions containing them
JP2014024874A5 (enExample)
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
PT2389070E (pt) Formulações desintegráveis de carbonato de lantânio
PH12014502221A1 (en) Prasugrel-containing immediate release stable oral pharmaceutical compositions
EP2497464A3 (en) Pharmaceutical composition of imatinibe methanesulphonate and a process for its manufacture
JP2012046484A5 (enExample)
PL2146951T3 (pl) Nowe ligandy agonistyczne receptorów RAR, zastosowanie w medycynie ludzi jak również w kosmetyce
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
EA201291189A1 (ru) Фармацевтическая композиция, содержащая солифенацин, и способ его получения